Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 70518-0942

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 70518-0942). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 01

Chemical structure of tramadol hydrochloride showing the molecular arrangement including functional groups and the HCl moiety.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 02

A line graph depicting tramadol concentration (ng/mL) over time (hours) comparing Tramadol Hydrochloride Extended-Release Tablets 200 mg taken once daily with Tramadol Hydrochloride Tablets 50 mg taken every six hours. Two lines represent concentration changes, illustrating pharmacokinetic profiles of the two dosages and formulations over a 24-hour period.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 03

A pharmacokinetic graph comparing M1 metabolite concentrations (ng/mL) over 24 hours between Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily and Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis shows time in hours and the y-axis shows M1 concentration.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 04

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' depicting the percent of patients achieving various response thresholds of pain improvement. The x-axis shows response thresholds as percent improvement from baseline (0-100%), and the y-axis shows the percent of patients achieving the response (0-60%). Lines represent different dosages of tramadol hydrochloride extended-release tablets (100 mg, 200 mg, 300 mg, 400 mg) and placebo, showing a trend of decreasing patient response rates as response thresholds increase.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 05

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis.' It shows the percent of patients achieving various response thresholds of pain improvement, comparing Tramadol Hydrochloride Extended-Release Tablets with placebo. The x-axis represents response threshold as percent improvement from baseline, ranging from 0 to 100. The y-axis represents the percent of patients achieving response, ranging from 0 to 60 percent. Two lines illustrate outcomes: one with open circles for Tramadol Hydrochloride and one with stars for placebo, with the Tramadol line consistently showing higher response percentages across thresholds.*

FDA Label Image

Tramadol HCl 100mg 70518 0942 00

Label for TRAMADOL HYDROCHLORIDE extended-release tablets, 100 mg strength, with quantity of 30 tablets. The label shows the drug is Schedule IV (C-IV) and is repackaged by RemedyRepack Inc. Manufacturer information for Lupin Pharma, Baltimore, MD is included, along with directions to see the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.